Bristol-Myers Squibb Company - stock earnings
BMY Upcoming estimated earnings
| Date | Low Revenue | Average Revenue | High Revenue |
|---|---|---|---|
| April 25, 2024 BeforeMarket | 11.1 billion | 11.4 billion | 11.7 billion |
BMY Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 1.8 billion USD | 11.5 billion USD |
| 2023Q3 | 1.9 billion USD | 11.0 billion USD |
| 2023Q2 | 2.1 billion USD | 11.2 billion USD |
| 2023Q1 | 2.3 billion USD | 11.3 billion USD |
| 2022Q4 | 2.0 billion USD | 11.4 billion USD |
| 2022Q3 | 1.6 billion USD | 11.2 billion USD |
| 2022Q2 | 1.4 billion USD | 11.9 billion USD |
| 2022Q1 | 1.3 billion USD | 11.6 billion USD |
| 2021Q4 | 2.4 billion USD | 12.0 billion USD |
| 2021Q3 | 1.5 billion USD | 11.6 billion USD |
| 2021Q2 | 1.1 billion USD | 11.7 billion USD |
| 2021Q1 | 2.0 billion USD | 11.1 billion USD |
| 2020Q4 | -10.0 billion USD | 11.1 billion USD |
| 2020Q3 | 1.9 billion USD | 10.5 billion USD |
| 2020Q2 | -85.0 million USD | 10.1 billion USD |
| 2020Q1 | -775.0 million USD | 10.8 billion USD |
| 2019Q4 | -1.1 billion USD | 7.9 billion USD |
| 2019Q3 | 1.4 billion USD | 6.0 billion USD |
| 2019Q2 | 1.4 billion USD | 6.3 billion USD |
| 2019Q1 | 1.7 billion USD | 5.9 billion USD |
| 2018Q4 | 1.2 billion USD | 6.0 billion USD |
| 2018Q3 | 1.9 billion USD | 5.7 billion USD |
| 2018Q2 | 373.0 million USD | 5.7 billion USD |
| 2018Q1 | 1.5 billion USD | 5.2 billion USD |
| 2017Q4 | -2.3 billion USD | 5.4 billion USD |
| 2017Q3 | 845.0 million USD | 5.3 billion USD |
| 2017Q2 | 916.0 million USD | 5.1 billion USD |
| 2017Q1 | 1.6 billion USD | 4.9 billion USD |
| 2016Q4 | 894.0 million USD | 5.2 billion USD |
| 2016Q3 | 1.2 billion USD | 4.9 billion USD |
| 2016Q2 | 1.2 billion USD | 4.9 billion USD |
| 2016Q1 | 1.2 billion USD | 4.4 billion USD |
| 2015Q4 | -138.0 million USD | 4.3 billion USD |
| 2015Q3 | 706.0 million USD | 4.1 billion USD |
| 2015Q2 | -130.0 million USD | 4.2 billion USD |
| 2015Q1 | 1.2 billion USD | 4.0 billion USD |
| 2014Q4 | 13.0 million USD | 4.3 billion USD |
| 2014Q3 | 721.0 million USD | 3.9 billion USD |
| 2014Q2 | 333.0 million USD | 3.9 billion USD |
| 2014Q1 | 937.0 million USD | 3.8 billion USD |
| 2013Q4 | 726.0 million USD | 4.4 billion USD |
| 2013Q3 | 692.0 million USD | 4.1 billion USD |
| 2013Q2 | 536.0 million USD | 4.0 billion USD |
| 2013Q1 | 609.0 million USD | 3.8 billion USD |
| 2012Q4 | 925.0 million USD | 4.2 billion USD |
| 2012Q3 | -711.0 million USD | 3.7 billion USD |
| 2012Q2 | 645.0 million USD | 4.4 billion USD |
| 2012Q1 | 1.1 billion USD | 5.3 billion USD |
| 2011Q4 | 852.0 million USD | 5.5 billion USD |
| 2011Q3 | 969.0 million USD | 5.3 billion USD |
| 2011Q2 | 902.0 million USD | 5.4 billion USD |
| 2011Q1 | 986.0 million USD | 5.0 billion USD |
| 2010Q4 | 483.0 million USD | 5.1 billion USD |
| 2010Q3 | 949.0 million USD | 4.8 billion USD |
| 2010Q2 | 927.0 million USD | 4.8 billion USD |
| 2010Q1 | 743.0 million USD | 4.8 billion USD |
| 2009Q4 | 8.0 billion USD | 2.9 billion USD |
| 2009Q3 | 966.0 million USD | 5.5 billion USD |
| 2009Q2 | 1.3 billion USD | 5.4 billion USD |
| 2009Q1 | 638.0 million USD | 5.0 billion USD |
| 2008Q4 | 1.2 billion USD | 5.2 billion USD |
| 2008Q3 | 2.6 billion USD | 5.3 billion USD |
| 2008Q2 | 764.0 million USD | 5.2 billion USD |
| 2008Q1 | 661.0 million USD | 5.2 billion USD |
| 2007Q4 | -89.0 million USD | 4.9 billion USD |
| 2007Q3 | 858.0 million USD | 5.1 billion USD |
| 2007Q2 | 706.0 million USD | 4.9 billion USD |
| 2007Q1 | 690.0 million USD | 4.5 billion USD |
| 2006Q4 | -134.0 million USD | 4.2 billion USD |
| 2006Q3 | 338.0 million USD | 4.2 billion USD |
| 2006Q2 | 667.0 million USD | 4.9 billion USD |
| 2006Q1 | 714.0 million USD | 4.7 billion USD |
| 2005Q4 | 499.0 million USD | 5.0 billion USD |
| 2005Q3 | 964.0 million USD | 4.8 billion USD |
| 2005Q2 | 1.0 billion USD | 4.9 billion USD |
| 2005Q1 | 533.0 million USD | 4.5 billion USD |
| 2004Q4 | 139.0 million USD | 3.3 billion USD |
| 2004Q3 | 758.0 million USD | 5.4 billion USD |
| 2004Q2 | 527.0 million USD | 5.4 billion USD |
| 2004Q1 | 964.0 million USD | 5.2 billion USD |
| 2003Q4 | 583.0 million USD | 5.8 billion USD |
| 2003Q3 | 884.0 million USD | 5.3 billion USD |
| 2003Q2 | 878.0 million USD | 5.1 billion USD |
| 2003Q1 | 761.0 million USD | 4.7 billion USD |
| 2002Q4 | 357.0 million USD | 4.5 billion USD |
| 2002Q3 | 357.0 million USD | 4.5 billion USD |
| 2002Q2 | 440.0 million USD | 4.1 billion USD |
| 2002Q1 | 1.5 billion USD | 5.3 billion USD |
| 2001Q4 | 1.5 billion USD | 5.3 billion USD |
| 2001Q3 | 1.2 billion USD | 4.7 billion USD |
| 2001Q2 | 1.2 billion USD | 4.7 billion USD |
| 2001Q1 | 1.2 billion USD | 4.8 billion USD |
| 2000Q4 | 1.2 billion USD | 4.8 billion USD |
| 2000Q3 | 1.2 billion USD | 4.6 billion USD |
| 2000Q2 | 1.1 billion USD | 5.3 billion USD |
| 2000Q1 | 1.2 billion USD | 5.3 billion USD |
| 1999Q4 | 1.1 billion USD | 5.4 billion USD |
| 1999Q3 | 1.1 billion USD | 5.0 billion USD |
| 1999Q2 | 952.0 million USD | 4.9 billion USD |
| 1999Q1 | 1.1 billion USD | 4.9 billion USD |
| 1998Q4 | 413.0 million USD | 4.9 billion USD |
| 1998Q3 | 966.0 million USD | 4.5 billion USD |
| 1998Q2 | 835.0 million USD | 4.4 billion USD |
| 1998Q1 | 927.0 million USD | 4.4 billion USD |
| 1997Q4 | 802.0 million USD | 4.4 billion USD |
| 1997Q3 | 855.0 million USD | 4.2 billion USD |
| 1997Q2 | 738.0 million USD | 4.1 billion USD |
| 1997Q1 | 810.0 million USD | 4.0 billion USD |
| 1996Q4 | 716.0 million USD | 4.0 billion USD |
| 1996Q3 | 753.0 million USD | 3.7 billion USD |
| 1996Q2 | 655.0 million USD | 3.7 billion USD |
| 1996Q1 | 726.0 million USD | 3.7 billion USD |
| 1995Q4 | -142.0 million USD | 3.6 billion USD |
| 1995Q3 | 689.0 million USD | 3.4 billion USD |
| 1995Q2 | 608.0 million USD | 3.4 billion USD |
| 1995Q1 | 657.0 million USD | 3.3 billion USD |
| 1994Q4 | 98.0 million USD | 3.2 billion USD |
| 1994Q3 | 621.0 million USD | 2.9 billion USD |
| 1994Q2 | 542.0 million USD | 3.0 billion USD |
| 1994Q1 | 581.0 million USD | 2.8 billion USD |
| 1993Q4 | 256.0 million USD | 3.0 billion USD |
| 1993Q3 | 608.0 million USD | 2.9 billion USD |
| 1993Q2 | 521.0 million USD | 2.8 billion USD |
| 1993Q1 | 575.0 million USD | 2.8 billion USD |
| 1992Q4 | 337.0 million USD | 2.4 billion USD |
| 1992Q3 | 589.0 million USD | 3.1 billion USD |
| 1992Q2 | 488.0 million USD | 2.9 billion USD |
| 1992Q1 | 548.0 million USD | 2.8 billion USD |
| 1991Q4 | 510.0 million USD | 2.9 billion USD |
| 1991Q3 | 563.0 million USD | 2.8 billion USD |
| 1991Q2 | 490.0 million USD | 2.7 billion USD |
| 1991Q1 | 493.0 million USD | 2.7 billion USD |
| 1990Q4 | 426.0 million USD | 2.7 billion USD |
| 1990Q3 | 496.0 million USD | 2.6 billion USD |
| 1990Q2 | 417.0 million USD | 2.5 billion USD |
| 1990Q1 | 409.0 million USD | 2.5 billion USD |
| 1989Q4 | ? USD | 2.4 billion USD |
| 1989Q3 | ? USD | 2.3 billion USD |
| 1989Q2 | ? USD | 2.2 billion USD |
| 1989Q1 | ? USD | 2.3 billion USD |
| 1988Q4 | ? USD | 2.1 billion USD |
| 1988Q3 | ? USD | 2.2 billion USD |
| 1988Q2 | ? USD | 2.1 billion USD |
| 1988Q1 | ? USD | 2.1 billion USD |
| 1987Q4 | ? USD | 1.9 billion USD |
| 1987Q3 | ? USD | 1.9 billion USD |
| 1987Q2 | ? USD | 1.9 billion USD |
| 1987Q1 | ? USD | 1.9 billion USD |
BMY Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 8.0 billion USD | 45.0 billion USD |
| 2022 | 6.3 billion USD | 46.2 billion USD |
| 2021 | 7.0 billion USD | 46.4 billion USD |
| 2020 | -9.0 billion USD | 42.5 billion USD |
| 2019 | 3.4 billion USD | 26.1 billion USD |
| 2018 | 5.0 billion USD | 22.6 billion USD |
| 2017 | 1.0 billion USD | 20.8 billion USD |
| 2016 | 4.5 billion USD | 19.4 billion USD |
| 2015 | 1.6 billion USD | 16.6 billion USD |
| 2014 | 2.0 billion USD | 15.9 billion USD |
| 2013 | 2.6 billion USD | 16.4 billion USD |
| 2012 | 2.0 billion USD | 17.6 billion USD |
| 2011 | 3.7 billion USD | 21.2 billion USD |
| 2010 | 3.1 billion USD | 19.5 billion USD |
| 2009 | 10.6 billion USD | 18.8 billion USD |
| 2008 | 5.2 billion USD | 20.6 billion USD |
| 2007 | 2.2 billion USD | 19.3 billion USD |
| 2006 | 1.6 billion USD | 17.9 billion USD |
| 2005 | 3.0 billion USD | 19.2 billion USD |
| 2004 | 2.4 billion USD | 19.4 billion USD |
| 2003 | 3.1 billion USD | 20.9 billion USD |
| 2002 | 2.1 billion USD | 18.1 billion USD |
| 2001 | 5.2 billion USD | 19.4 billion USD |
| 2000 | 4.7 billion USD | 18.2 billion USD |
| 1999 | 4.2 billion USD | 20.2 billion USD |
| 1998 | 3.1 billion USD | 18.3 billion USD |
| 1997 | 3.2 billion USD | 16.7 billion USD |
| 1996 | 2.9 billion USD | 15.1 billion USD |
| 1995 | 1.8 billion USD | 13.8 billion USD |
| 1994 | 1.8 billion USD | 12.0 billion USD |
| 1993 | 2.0 billion USD | 11.4 billion USD |
| 1992 | 2.0 billion USD | 11.2 billion USD |
| 1991 | 2.1 billion USD | 11.2 billion USD |
| 1990 | 1.7 billion USD | 10.3 billion USD |
| 1989 | 747.0 million USD | 9.2 billion USD |
| 1988 | 1.3 billion USD | 8.6 billion USD |
| 1987 | 1.1 billion USD | 7.6 billion USD |
BMY
List: Contenders
Price: $48.93
52 week price:
Dividend Yield: 0.04%
5-year range yield:
Forward Dividend Yield: 4.90%
Payout Ratio: 62.18%
Payout Ratio Range:
Dividend Per Share: 2.40 USD
Earnings Per Share: 3.80 USD
P/E Ratio: 12.90
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 10.2 million
Ebitda: 946.0 millionMarket Capitalization: 104.2 billion
Average Dividend Frequency: 4
Years Paying Dividends: 53
DGR3: 8.88%
DGR5: 7.07%
DGR10: 4.91%
DGR20: 3.52%